EP Wealth Advisors LLC bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 9,027 shares of the pharmaceutical company’s stock, valued at approximately $4,484,000. A number of other hedge funds and other institutional […]